BACKGROUND: The impact of gut microbiota on the regulation of host physiology has recently garnered considerable attention, particularly in key areas such as the immune system and metabolism. These areas are also crucial for the pathophysiology of and repair after myocardial infarction (MI). However, the role of the gut microbiota in the context of MI remains to be fully elucidated.
A
n astounding number and diversity of microbes are present at any given moment throughout the human body. Through coevolution, these microbes and their animal hosts have developed a mutualistic relationship in which their biological interaction has become essential for survival. In particular, there is accumulating evidence that specific bacterial species can play immunomodulatory roles in their host. Recent studies have shown that gut microbiota can influence the composition, migration, and function of various immune cell subpopulations. With different members of the gut microbiota capable of affecting host immune homeostasis in different ways, the heterogeneity of this community may be the basis of individual differences in host immune response. 1, 2 Given the integral role of the immune system during wound repair, it comes as no surprise that gut microbiota have been implicated in the repair of a variety of tissues. These range from those inside the body such as the gastrointestinal tract 3 and liver 4 to surfaces exposed to the external environment such as the skin. 5 Involvement of gut microbiota has already been implicated in cardiovascular disease, with evidence linking dietary choline and gut microbiota trimethylamine N-oxide production to atherosclerosis through augmentation of macrophage cholesterol accumulation, foam cell formation, and exacerbated thrombosis. 6 Recent reports have highlighted a relationship between gut microbiota and severity of myocardial infarction (MI), which remains the leading cause of mortality across all industrialized nations, with 1 million Americans estimated to have new or recurrent MI each year. 7 Dysbiosis caused by antibiotics (ABX) has been shown to alter the composition 8 and metabolism 9 of gut microbiota, which may have an impact on outcome after MI. However, the exact role of the gut microbiota and the mechanisms behind their involvement in effective endogenous cardiac repair after MI remain to be uncovered.
An enormous body of evidence now demonstrates that the inflammatory responses occurring after MI play critical roles during cardiac repair 10, 11 and are driven by many different cell types. Apoptotic neutrophils in the injured myocardium stimulate macrophage recruitment and promote the clearance of necrotic debris and apoptotic cells. Ablation of neutrophils in genetic knockout models has been shown to result in worse cardiac function and increased fibrosis after MI. 12, 13 In addition, macrophages derived from recruited monocytes or other similar precursors build inflammatory microenvironments to activate cardiofibroblasts for cardiac remodeling and endogenous stem cells for heart regeneration by either cell fusion or transdifferentiation.
14 As an important immune modulator, we therefore hypothesized that gut microbiota may have an impact on the efficiency of repair after MI. To test this, we used an ABX-induced model of dysbiosis to examine the association between gut microbiota and the immune system in the context of MI. We show strong evidence that gut microbiota play an essential role in effective cardiac repair and that this may be through the production of specific short-chain fatty acids (SCFAs) that can modulate the immune system and therefore the inflammatory microenvironment after MI.
METHODS
Detailed methods are available in the online-only Data Supplement. The data, analytical methods, and study materials for the purposes of reproducing the results or replicating procedures can be made available on request to the corresponding author who manages the information. All experiments involving animals were conducted in accordance with the Guide for the Use and Care of Laboratory Animals. All animal protocols were approved by the Institutional Animal Care and Use Committee of Academia Sinica. The animal protocol for germ-free mouse experiment was approved by the Institutional Animal Care and Use Committee of the University of Wisconsin-Madison.
Animals
C57BL/6J mice were purchased from the National Laboratory Animal Center, Taiwan. CX3CR1-GFP (enhanced green fluorescent protein; B6.129P-Cx3cr1 tm1Litt /J) transgenic mice were purchased from The Jackson Laboratory. Eight-to 10-weekold male and female animals were used for the experiments as indicated. Mice under different treatments were housed separately in individually ventilated cages in the Academia Sinica SPF Animal Facility. Eight-week-old germ-free male C57BL/6J mice were maintained in plastic flexible film gnotobiotic isolators under a strict 12-hour light cycle and fed autoclaved water and diet in the Germ-Free Mouse Facility at the University of Wisconsin-Madison. The mice were numbered and the cages were housed in a random order on the shelves. All measurements were done in a random order, and
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Surgery and Echocardiography
To induce MI, the left anterior descending coronary artery was permanently ligated at 2 to 3 mm distal to the left atrial appendage, as previously described. 15 At 21 days after MI, cardiac function was assessed by echocardiography with Vivid-q Ultrasound equipped with a 5-to 13-MHz intraoperative probe (GE).
ABX Treatment
To prepare the ABX cocktail, ampicillin (0.25 mg/mL), metronidazole (0.25 mg/mL), neomycin (0.25 mg/mL), and vancomycin (0.125 mg/mL; Sigma) were dissolved in autoclaved water. These concentrations represent the maximal dose given to the mice; for the dose-dependency studies, a half, quarter, or eighth of this dose was given. Sucralose (Splenda; 12 mg/mL) was added to make the mixture more palatable and was added to the water of untreated controls. In experiments in which ABX were administered before MI, treatment was initiated 7 days before surgery. Animals that received the ABX cocktail are referred to as ABX mice, whereas those that did not are referred to as untreated mice.
High-Performance Liquid Chromatography Measurement of SCFAs
Blood serum and fecal samples were collected immediately after the animals were euthanized and snap-frozen in liquid nitrogen. On thawing, feces were homogenized in 1 mL highperformance liquid chromatography (HPLC)-grade water and centrifuged at >14 000g. The resulting supernatant was then passed through a 0.22-μm syringe filter to remove bacterial cells and debris. Samples were then acidified with 10% to 20% vol/vol 0.01 mol/L H 2 SO 4 . Analysis of SCFA composition was performed with a Waters Alliance e2659 HPLC with a Waters 2489 UV/Vis detector and a Waters XBridge C18 RP column (5 µm, 4.6×250 mm). H 2 SO 4 (0.01 mol/L) was used as the mobile phase. SCFAs were identified by comparing sample peak retention times with standards, and concentrations were determined by an external standard calibration method using the Waters Empower 3. All samples and standards were prepared as described above. SCFA concentrations were standardized by weight.
Statistics
Statistical analyses of all data were performed with GraphPad Prism. Results are presented as mean±SEM. The KaplanMeier method and log-rank (Mantel-Cox) test were used to construct and compare the survival curves of animals, respectively. In the body weight study, 2-way repeated-measures ANOVA, followed by a Tukey adjustment for multiple comparisons, was used to account for the correlation of serial measurements in the same animal. One-way ANOVA with the Tukey adjustment for multiple comparisons was used to compare the effects of treatments (control, fecal transplantation, SCFA, and monocyte transplantation) on the disease models (sham and MI). The 2-sample Student t test was used to compare the data of control and probiotic-treated mice. A value of P<0.05 was considered statistically significant.
RESULTS

Predepletion of Gut Microbiota Causes High Mortality After MI
To determine the importance of the gut microbiota for cardiac repair after MI, we administered to male mice oral ABX 7 days before induction of MI to predeplete the gut microbiota before injury. 16s rDNA quantification of bacterial load in feces collected from ABX and untreated mice was used to assess the degree of depletion ( Figure 1A and Figure IA in the online-only Data Supplement). Survival was subsequently monitored over the course of a 21-day follow-up after MI. When administering the maximal ABX dose, we observed that the mortality rate of ABX mice was drastically increased compared with untreated mice, with the majority of ABX mice dying during the first week after MI ( Figure 1B and Figure IB in the online-only Data Supplement). Furthermore, we observed that reducing the ABX dosage restored survival in a dose-dependent manner ( Figure 1C and 1D ). Pathological analysis of the heart morphology revealed that the leading cause of early death of the ABX mice after MI was rupture in the left ventricles ( Figure 1E , Table, and Figure IC in the online-only Data Supplement). In male germ-free mice, we also observed a trend of decreased survival and an increased incidence of heart rupture after MI ( Figure ID and IE in the online-only Data Supplement). Female ABX mice had a better survival rate compared with age-matched male ABX mice ( Figure IF in the online-only Data Supplement). Crucially, by reconstituting the gut microbiota through fecal transplantation from untreated mouse donors before MI, we could significantly improve survival to 67% in the ABX mice ( Figure 1F and 1G). Although ABX treatment in the absence of heart injury (non-MI mice) caused weight loss in the ABX mice, this treatment did not have an effect on ejection fraction or fractional shortening, as indicated by echocardiographic assessment ( Figure IIA and IB in the online-only Data Supplement). ABX treatment did not alter the systolic and diastolic pressures, heart rate, or serum biochemical index of non-MI mice ( Figure IIC and Table I in the online-only Data Supplement). Administrating ABX through either drinking water or gavage showed the same trend of decreased body weight, which may be attributed to the loss of water and lean weight ( Figure III in the online-only Data Supplement). Heart weight was also decreased in ABX mice and could be another contributing factor to poor survival rate. Furthermore, except for a modest but significant increase in the level of tumor necrosis factor-α, the other systemic inflammatory cytokine ORIGINAL RESEARCH ARTICLE levels were not altered after ABX treatment ( Figure  IV in the online-only Data Supplement). Collectively, these findings suggest that the gut microbiota play an integral role during cardiac repair, especially during the initial stages after infarction, and that this is essential for survival.
Gut Microbiota Participate in Postinfarction Repair Through Immune Modulation
Participation of gut microbiota in the modulation of inflammatory responses, especially the development and function of myeloid cells in multiple organs, has been reported previously. 2, 16 Similar to previous reports using germ-free mice, 16 flow cytometric analysis of organ extracts from non-MI ABX mice showed a significant reduction of myeloid cells and neutrophils in the spleen, bone marrow (BM), and peripheral blood mononuclear cells compartments ( Figure V in the online-only Data Supplement). These cell populations were also decreased in the heart on ABX treatment both before and after MI ( Figure 2A ) but were restored on microbiota reconstitution ( Figure 2A ). Flow cytometric analysis and intravital imaging of CX3CR1-GFP mice, within which leukocytes constitutively express GFP, after MI also showed impaired immune balance on ABX treatment ( Figure 2B and 2C). In particular, through intravital imaging, we observed a drastic decrease in GFP + cell infiltration to the periinfarct zone of ABX mice compared with untreated mice that was rescued on reconstitution ( Figure 2B ). After these findings, we found that we were able to mitigate the high postinfarction mortality of ABX mice and to improve survival to 64% by transplanting a monocytic cell line, RAW264.7, even 1 day after MI (Figure 2D through 2F) . Further analysis showed that the populations of CD4 + Foxp3 − T cells, regulatory T
Figure 1. Predepletion of gut microbiota causes high mortality after myocardial infarction (MI).
A, Quantification of the bacterial load based on 16S rDNA content per 1 mg fecal and heart samples collected from antibiotics-treated (ABX; n=6) mice or untreated (n=6) mice. B, Survival rate of ABX or untreated mice after MI. C, Dose dependency of ABX microbiota depletion based on quantification of bacterial load in mice treated with different ABX doses (n=3) or untreated mice (n=3). D, Dose dependency of ABX-induced mortality after MI based on the survival rate of mice treated with varying ABX doses or untreated mice. E, An example of an ABX mouse ruptured heart (bright-field and microscopic images stained by hematoxylin and eosin). F, Efficiency of microbiota reconstitution based on quantification of bacterial load in ABX, untreated, or fecal-reconstituted ABX mice. G, Survival rate of ABX, untreated, or fecal-reconstituted ABX mice after MI. Two-sample Student t test was used to compare the data in A. The Kaplan-Meier method and the log-rank (Mantel-Cox) test were used to construct and analyze the survival curves in B, D, and G. One-way ANOVA with a Tukey adjustment was used for data analysis in C and F. n.s. indicates not significant. **P<0.01; ***P<0.001.
Circulation. Figure VI in the online-only Data Supplement). We observed a trend of an increase in regulatory T cells in the hearts of the ABX mice that received Raw264.7 cell transfer, although it was not statistically significant (Figure VIB in the online-only Data Supplement). These findings suggest that ABXdriven depletion of the gut microbiota may have an effect on the composition of the immune system, in particular within the myeloid cell compartment, leading to impaired cardiac repair and the increased mortality we observed after MI.
Gut Microbiota-Derived SCFAs Play a Role in Immune Modulation and Postinfarction Repair
The gut microbiota continually produce numerous metabolites such as amino acids, fatty acid, vitamins, uremic toxins, and SCFAs. Emerging evidence suggests that some of these metabolites can influence the host immune response. 17 SCFAs such as acetate, propionate, and butyrate are end products of bacterial anaerobic fermentation of microbiota-accessible carbohydrates. Recent work has demonstrated that SCFAs drive myelopoiesis in the BM 16, 18 and, in addition to affecting circulating myeloid cells, strongly influence the biology of tissue-resident macrophages. 19, 20 We therefore hypothesized that these metabolites may underlie the effect of the gut microbiota on immune composition and postinfarction repair that we observed. Through HPLC analysis, we found that depletion of the gut microbiota resulted in a reduction of acetate, butyrate, and propionate proportions in serum and fecal samples ( Figure 3A) . Supplementation with just these 3 SCFAs before MI appeared to be effective for rescuing survival by 50% in ABX mice ( Figure 3B ). Similar to previous reports, supplementation of SCFA strengthened the tight junction barrier of the intestinal epithelium ( Figure VII in the onlineonly Data Supplement). [21] [22] [23] Flow cytometric analysis of organ extracts from non-MI ABX mice showed that SCFA supplementation did not alter the percentage of myeloid cells in the spleen, BM, and peripheral blood mononuclear cell compartments ( Figure  VIII in the online-only Data Supplement). However, SCFA supplementation was sufficient to restore the level of myeloid cells in ABX CX3CR1-GFP mice and CX3CR1-GFP + cell infiltration to the peri-infarct zone ( Figure 3C through 3E) . These findings suggest that SCFAs are key actuators through which the gut microbiota can modulate the immune system. By showing that SCFA supplementation was sufficient to improve survival, we provide evidence that the loss of these submetabolites cripples the immune system and subsequent cardiac repair after MI.
Gut Microbial Community Structure Influences the Severity of MI
It has previously been reported that many diseases are transmissible through microbiota transplantation, including metabolic syndrome 24 and infectious diseases. 25 We therefore investigated whether there would be a difference in outcome after infarction between ABX mice receiving fecal transplants from untreated MI mice and those receiving fecal transplants from non-MI mice ( Figure IXA in the online-only Data Supplement). Using echocardiographic analysis, we found that mice receiving microbiota transplants from MI donors had statistically significant worse heart function 21 days after MI ( Figure IXB and IXC in the online-only Data Supplement). Although the bacterial load in feces and heart showed no differences ( Figure 4A ), further investigation of fecal DNA extracted revealed shifts in gut microbial community structure before and after MI ( Figure 4B ). More specifically, significant differences occurred across the Lactobacillus, Prevotella, Clostridium, and Oscillospira genera ( Figure 4C ). Lactobacillus is a well-known probiotic and has been reported to exert numerous health benefits. 26 Indeed, a recent study looking at supplementation of different species of Lactobacillus in rats showed cardioprotective effects when administered after MI. 9 Although supplementing ABX mice with a Lactobacillus probiotic cocktail resulted in no significant difference in the survival rate after MI compared with the milk and water control groups ( Figure XA 
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Systems to specific bacterial metabolic pathways, the algorithm predicted that mice on MI day 3 had microorganisms enriched for human diseases and metabolism ( Figure XIB in the online-only Data Supplement). Further analysis revealed that the prominent pathway in mice on MI day 3 was nucleic acid metabolism such as purine metabolism and RNA degradation ( Figure XIC in the online-only Data Supplement). These findings indicate that microbial composition has an impact on cardiac repair after MI and that specific gut microbes can singularly mediate therapeutic effects.
Lactobacillus Probiotic Supplementation Alters SCFA Metabolism, Thereby Modulating Immune Response
To uncover the mechanism underlying the benefits of probiotic supplementation, we performed flow cyto- ORIGINAL RESEARCH ARTICLE metric and HPLC analysis to examine the differences in immune composition and SCFA metabolism in Lactobacillus-based cocktail-supplemented and nonsupplemented mice. We found that probiotic supplementation was associated with an increase in the level of myeloid cells in the hearts of non-MI and MI ABX mice ( Figure 5A ). Although HPLC analysis showed that total SCFA content in blood serum and fecal samples did not change after probiotic supplementation ( Figure 5B and 5D and Figure XII in the online-only Data Supplement), further examination revealed a difference in the composition of SCFA metabolites. More specifically, the level of propionate was significantly increased, accompanied by a reduction of butyrate after probiotic supplementation ( Figure 5C and 5E). To investigate whether propionate could mediate any organ-specific effects, we supplemented untreated mice that had intact gut microbiota with additional propionate. Immune composition in multiple organs was subsequently analyzed by flow cytometry. Under these conditions, we found that propionate supplementation did not affect the level of myeloid cells in the spleen, BM, and peripheral blood mononuclear cells ( Figure XIII in the online-only Data Supplement). However, we found a significant increase 
ORIGINAL RESEARCH ARTICLE
in the level of myeloid cells in the heart, regardless of the presence or absence of MI ( Figure 5F ). Collectively, these findings demonstrate that gut microbiota coabundance groups and metabolites such as the SCFA propionate are capable of modulating the host immune system and physiology.
DISCUSSION
Administration of ABX is common in cardiovascular surgery to prevent surgical site infection. Nevertheless, overuse of ABX in the clinic may lead to ABX resistance, which increases the morbidity and mortality of patients after surgical intervention or with infectious diseases. 29 In addition, ABX overuse also increases the risk of type II diabetes mellitus, although the detailed mechanisms remain to be determined. 30 In a mouse stroke model, depletion of gut microbiota causes host immune depression and worsens the outcome of stroke. 31 It has been shown that feeding hypertensive mice a high-fiber diet may prevent the development of hypertension and heart failure, which could be attributed to increased acetate-producing bacteria in the gut microbiota. 32 All these reports suggest a correlation between gut microbiota and the clinical outcome of diseases. In our report, we demonstrated a relationship between gut microbiota and the outcome of MI by modulating the host immune system. However, there are limitations to our study. A recent study reported that commensal fungi, which make up <1% of the gut microbial community, are able to exert effects on the host after infarction in the same way as gut bacteria. 33 The use of a fungi-free or bacteria-free treatment for further analysis will be necessary for our future study.
The immune system plays a critical role during and after injury in driving both the pathophysiology of and recovery from MI. Indeed, it has been shown that the inflammatory microenvironment, especially at early time points after MI, is crucial for initiating endogenous repair and that abrogating this response leads to worse outcome. 10, 15 It is also now becoming clear that the gut microbiota can influence the host immune system 16 Studies in germ-free mice show a global defect in myeloid cell populations at primary immune sites, which shows how the gut microbiota can shape immune architecture early in development. 16 These cell types play an integral role during postinfarction repair. In our study, we treated mice with A, Assessment of immune cell components in the hearts of antibiotics-treated (ABX) mice fed water, milk, or probiotics at 3 days after myocardial infarction (MI3D). B, Quantification of SCFA content in feces collected from ABX mice fed either water or probiotics by high-performance liquid chromatography (HPLC). C, Specific changes in acetate, butyrate, and propionate levels per 1 mg feces. D, Quantification of SCFA content in blood serum collected from ABX mice fed either water or probiotics by HPLC. E, Specific changes in acetate, butyrate, and propionate levels per 1 µL blood serum. F, Assessment of immune cell components in the hearts of untreated mice fed water or a 200-mmol/L propionate supplement on MI3D. One-way ANOVA with a Tukey adjustment was used for data analysis in A. The 2-sample Student t test was used for data analysis in B through F. n.s. indicates not significant. **P<0.01; ***P<0.001.
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oral ABX to predeplete the gut microbiota before MI and found that this drastically increased mortality after injury in a dose-dependent manner. We also observed a similar trend, namely that dysbiosis of gut microbiota leads to a high mortality rate in mice after MI in the male germ-free mouse model. Although the survival rate of germ-free mice after MI was higher than that in ABX mice after MI, this difference may be a result of the absence of a mature immune system in the germfree mice. 34 Although ABX mice no longer bear heavy microbial load in their intestines, the previous presence of the gut microbiome has already primed and matured the immune system. Further investigation showed that this dysbiosis was associated with systemic changes in the murine host, with proportions of myeloid cells and SCFAs similarly becoming depleted. Reflecting these changes, intravital imaging of CX3CR1-GFP reporter mice showed reduced immune activity in the peri-infarct zone, suggesting an absence of repair response after MI. Crucially, by reconstituting the system at the level of the gut microbiota (through fecal transplants) or the immune system (through monocyte transplantation) or with solely the SCFAs by themselves, we were able to replete the immune system, to restore immune activity in the peri-infarct zone, and to improve survival after MI. Because ABX treatment did not affect survival in the absence of injury, the increased mortality could be caused by the capacity for repair becoming crippled before MI as a result of impairment of the immune system on loss of the gut microbiota and their associated metabolites ( Figure 6A ). Of course, we cannot completely exclude the contribution of the immunosuppressive ABX activity to the phenomena observed in this study because broad-spectrum ABX treatment has been reported to exert an immunosuppressive effect on the immune cell homeostasis in the intestines. 35, 36 However, our results highlight gut microbiota as a pivotal element in recovery from MI.
A paradigm is emerging that purports that metabolites produced by the gut microbiota enable them to extend beyond their local environment and affect the pathophysiology of remote organs in the host. 37 SCFAs such as acetate, propionate, and butyrate are breakdown products of dietary fiber and can signal to the host through a variety of pathways, including through G protein-coupled receptors such as GPR41 and GPR43, which are involved in the regulation of inflammation and enteroendocrine homeostasis. 38 In particular, SCFAs not only can affect the circulating myeloid cells 16, 18 but also can influence the biology of tissue-resident macrophages. 19, 20 Gut microbiota diversity and blood serum proportions of SCFAs have been linked to degree of myelopoiesis in the host, in addition to maturation of myeloid cells in the BM during hematopoiesis and after circulation. 16, 18 Extending these previous reports, our study specifically highlights the immunomodulatory role of these SCFAs and links them to repair after injury in the host heart. As mentioned, we observed that SCFA supplementation alone was sufficient to rescue several elements of dysbiosis. However, we note that this was to a limited extent (50%), which points toward the involvement of other metabolites; indeed, catabolism of aromatic amino acids has been linked to the severity of ischemia/reperfusion injury in rats. 8 Ultimately, this reinforces the notion that these metabolites are key mediators by which the gut microbiota exert their biological influence on host physiology, with the immune system being an interface for this relationship.
With this interdomain signaling axis in mind, the composition of the gut microbiota and differences in metabolite production across the diverse range of microbiota species also become even more prescient. Indeed, several studies have linked gut microbiota composition to human health and disease, with different species mediating specific and nonredundant effects on host pathophysiology. Stress conditions have also been reported to result in dysbiosis and decreased microbiota diversity. 39 Accordingly, we observed a shift in gut microbial composition across several genera on MI. We became specifically interested in the decrease in the proportion of Lactobacillus because of its previously reported health benefits and wide use as a probiotic. Probiotics are defined as live microorganisms that are administered to confer health benefits to the host, 40 and several have shown cardiovascular benefits such as reduction of cholesterol and hypertension. 41 Gan et al 9 provided the first evidence that a Lactobacillus probiotic may be cardioprotective in rats subjected to cardiac ischemia/reperfusion injury, although this was in animals with an intact gut microbiota. In our study, not only did we provide more stringent evidence that Lactobacillus can confer cardioprotective effects by investigating microbiota-depleted mice, but we also showed that supplementation was associated with increased proportions of myeloid cells in the heart, in addition to circulating and fecal propionate. This reiterated our findings in the rest of the study and led us to further investigate the physiological effects of propionate supplementation in healthy mice. Taken together, our results suggest that manipulating the gut microbiota with specific probiotics such as Lactobacillus can modulate host physiology in a clinically relevant manner. Previously, Gan et al 9 reported a cardioprotective phenomenon resulting from post-MI treatment of ABX, whereas in our study, we observed that pre-MI treatment of ABX resulted in dose-dependent mortality. These seemingly contradictory observations could be the result of the biphasic nature of inflammation after MI. 43 The first phase involves the initial infiltration of the immune system into the injury site characterized by an entry of leukocytes to remove necrotic debris and initiate repair. Recent studies have also suggested that sub- 42 This is followed by a second phase, characterized by efferocytosis, which is performed mainly by macrophages to resolve the inflammatory response. 42 However, an overactive or prolonged inflammatory response at this point, resulting from unrestrained spatial or temporal activity, leads to aggravation of viable areas of the myocardium through aberrant expansion of cardiomyocyte apoptosis and fibrosis, thus resulting in additional dysfunction. 43 In this sense, inflammation after MI can be both reparative and destructive. If we assume that ABX-mediated dysbiosis causes the same downstream immune impairment across each time point, whether the timing of this corresponds to the reparative or destructive phase could be the basis of this discrepancy in the outcome. Further studies are needed to confirm this hypothesis, and it remains to be seen whether this finding is translatable. A, In untreated mice, gut microbiota-derived SCFAs modulate immune composition and repair capacity during homeostasis. B, On antibiotics-mediated dysbiosis, the depletion of the gut microbiota and the SCFA products is associated with changes in immune composition and an abolishment of repair response, leading to exacerbated mortality after myocardial infarction (MI). Restoration of the system across each level through the fecal reconstitution of the gut microbiota, dietary supplementation of SCFAs, or immune cell transplantation results in improved survival.
Conclusions
Our findings provide evidence that depletion of the gut microbiota can be linked to changes in immune composition, thereby leading to defective repair and exacerbated mortality after MI. In this way, we show evidence supporting an interdomain signaling axis in which gut microbiota-derived metabolites such as SCFAs interface with the host immune system to actuate gut microbiota modulation of host physiology and injury response ( Figure 6B ). This indicates that the gut microbiota is a crucial element necessary for optimal cardiac repair after MI. Furthermore, we show that MI results in a change in the community structure of gut microbiota such as a reduction in the proportion of Lactobacillus. Supplementing ABX mice with a Lactobacillus probiotic showed cardioprotective effects but notably resulted in a shift in host SCFA balance toward propionate. Thus, a better understanding of the mechanisms underlying host-microbiota interactions could provide new directions for the development of therapies for treating ischemic heart disease, either through manipulating the gut microbiota or by mimicking these interactions on a molecular level. Furthermore, our results here provide an in-depth understanding of the effects of ABX abuse on the clinical outcomes.
